ROP:NASDAQRoper Technologies, Inc. Analysis
Data as of 2026-05-25 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Roper Technologies (ROP) is trading at $326.94, notably below its DCF‑derived fair value of $349.95, indicating a ~7% discount and an upside potential of roughly 39% per the computed upside/downside metric. The stock sits under its 20‑day SMA (338.76) and 50‑day SMA (348.31) and the 200‑day SMA remains far higher at 423.59, confirming a bearish price trend, yet the 14‑day RSI of 39 suggests the shares are approaching oversold territory. Momentum indicators reinforce this view, with the MACD line at –8.33 crossing below its signal line (–7.34), producing a bearish histogram, but the stable volume and low beta of 0.35 point to limited price volatility relative to the market. On the fundamentals side, ROP delivers 11.3% revenue growth, a robust gross margin of 69%, and a forward P/E of 13.68 versus an industry average of 39.5, underscoring a compelling blend of growth and value characteristics. The company’s dividend of $0.91 per share (1.11% yield) with a modest payout ratio of 21% is supported by strong operating cash flow ($2.6B) and free cash flow ($2.17B), making the dividend sustainable. Recent material news includes a Zacks Rank 1 Strong Buy upgrade and board approval of the upcoming dividend, both reinforcing investor confidence. While short‑term technicals remain bearish, the combination of undervaluation, solid cash generation, and a low‑risk profile suggests buying opportunities for patient investors.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below fair value and technical oversold signals
- Sustainable dividend with low payout ratio
- Stable volume and low beta limiting downside risk
Medium Term
1–3 yearsKey Factors
- Forward P/E of 13.68 versus industry average of 39.5
- Revenue growth of 11.3% and strong operating margins
- Analyst upgrade to Zacks Rank 1 Strong Buy
Long Term
> 3 yearsKey Factors
- Diversified technology and software portfolio with recurring revenue
- Consistent free cash flow supporting dividend and reinvestment
- Undervalued relative to DCF and attractive upside potential
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.